Allergy Therapeutics Balance Sheet
Allergy Therapeutics's total assets for Q2 2026 were £71.00M, an increase of 5.12% from the previous quarter. GB:AGY total liabilities were £66.75M for the fiscal quarter, a -30.27% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.